| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 77.10B | 74.23B | 62.79B | 65.90B | 65.90B | 64.73B |
| Gross Profit | 23.40B | 22.31B | 19.13B | 20.05B | 21.54B | 21.63B |
| EBITDA | 9.10B | 8.55B | 7.55B | 10.17B | 12.00B | 11.81B |
| Net Income | 4.21B | 3.54B | 4.67B | 6.65B | 7.66B | 7.55B |
Balance Sheet | ||||||
| Total Assets | 141.08B | 139.34B | 135.02B | 139.37B | 135.61B | 138.56B |
| Cash, Cash Equivalents and Short-Term Investments | 15.27B | 15.84B | 15.17B | 45.60B | 47.03B | 47.69B |
| Total Debt | 16.41B | 14.50B | 10.44B | 921.00M | 1.03B | 1.02B |
| Total Liabilities | 43.68B | 41.90B | 36.19B | 27.77B | 27.21B | 29.84B |
| Stockholders Equity | 95.62B | 95.67B | 97.17B | 110.01B | 106.82B | 107.25B |
Cash Flow | ||||||
| Free Cash Flow | 3.55B | 3.62B | -684.00M | 3.81B | 7.78B | 8.65B |
| Operating Cash Flow | 8.29B | 6.21B | 1.10B | 4.95B | 8.79B | 9.29B |
| Investing Cash Flow | -4.07B | -3.40B | -6.93B | -3.17B | -2.32B | -538.00M |
| Financing Cash Flow | -1.03B | -2.38B | -24.41B | -4.23B | -6.87B | -3.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥46.48B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
72 Outperform | ¥750.30B | 18.66 | 18.72% | 2.94% | 2.90% | 36.64% | |
66 Neutral | ¥113.49B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥128.71B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥69.28B | 12.73 | ― | 3.27% | 12.09% | 5.46% | |
52 Neutral | ¥471.59B | 16.11 | 1.44% | 4.80% | 0.68% | ― |